Our Company

Our Company

SkinDNA International is an Australian pharmaco genomics company founded by leading researchers and specialists in genetic analysis and skin therapies.

The company is dedicated to the research and development of new therapies for skin improvement tailored to an individuals genetic structure. SkinDNA International’s technology and training modules have been internationally adopted and implemented through various products around the globe.


Our Story

Its a fact of life that our genes play a large role in determining who we are, also who we will become.
The evidence of this isn't limited to the realm of science, it’s expressed in our everyday sayings like “you have your mothers eyes”, “Your great uncles nose”, but even in the everyday, the biological outcomes of our organs is determined in large part by our genes, and since the skin is the body’s largest and one of the most critical organs, we set out to determine which genes play a role in this determination.

DNA SCIENCE
Through DNA Science we know that a single gene consists of a unique sequence of DNA that provides the complete set of instructions to make a protein. Genes instruct cells to make sets of proteins at just the right times, and it is through this specificity that our uniqueness arises.

The concept of uniqueness is important because even though the DNA of any two individuals is more than 99.8% identical, everyone is genetically unique. The crucial difference lies in the remaining 0.2% differences most typically represented as variations known as Single Nucleotide Polymorphisms or (SNPs pronounced ‘snips’). DNA Science has helped to identify that many of these SNPs have been associated with an increased risk of disease including breast cancer, melanoma and diabetes - to name a few.
But the influence of SNPs doesn't stop with disease, they determine most of our personal characteristics - everything from the colour and thickness of our hair to the shape of our nose and, as recently discovered, the youth and vitality of our skin.

That is where findings from the global SkinDNA research collaboration led by Australian pharmaco genomics company SkinDNA International comes in.

Today, SkinDNA International distributes its technology worldwide directly, through distributors, and as “White Label” solutions where SkinDNA has assisted in co-branding or rebranding for distribution.